Presbyopia Drops: A Foundation for Future Care - Takeaways - MDSpire

Presbyopia Drops: A Foundation for Future Care

Presbyopia drops are more than just a new tool—they’re a strategic entry point into the lifelong care pathway for patients with presbyopia.

  • By

  • Mitchell A. Jackson, MD

  • Melissa Bollinger, OD, FAAO

  • November 1, 2025

  • 7 min

Share

  • 1

    Presbyopia drops serve as a strategic entry point into lifelong eye care, addressing immediate concerns while fostering long-term patient relationships.

  • 2

    Currently, three presbyopia drops are FDA-approved: Qlosi, Vuity, and Vizz, providing non-surgical alternatives for early-to-moderate presbyopes.

  • 3

    Customizability of presbyopia drops allows flexible dosing, empowering patients to manage their vision based on personal needs and lifestyles.

  • 4

    Clear communication about the temporary nature of presbyopia drops and the importance of neuroadaptation enhances patient satisfaction and retention.

  • 5

    Early engagement with presbyopia drops encourages proactive patient involvement in eye care, improving long-term outcomes and satisfaction.

Original Source(s)

Presbyopia Drops: A Foundation for Future Care

  • by Mitchell A. Jackson, MD, Melissa Bollinger, OD, FAAO

  • November 1, 2025

Related Content

Outcomes of Vision with a Diffractive Trifocal Intraocular Lens in Patients with Short Axial Length

Evaluating Postoperative Visual Performance and Reading Abilities of a Non-Diffractive EDOF IOL Compared to a Monofocal IOL: A Randomized Controlled Study on Eye Movements

Presbyopia Drops, a Promising Solution

While over-the-counter, prescription corrective lenses, and surgical interventions have been the mainstays of presbyopia management, presbyopia drops offer a non-invasive alternative.